These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 12672771

  • 1. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
    Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J.
    JAMA; 2003 Mar 26; 289(12):1537-45. PubMed ID: 12672771
    [Abstract] [Full Text] [Related]

  • 2. Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.
    Shekelle P, Hardy ML, Morton SC, Maglione M, Suttorp M, Roth E, Jungvig L, Mojica WA, Gagné J, Rhodes S, McKinnon E.
    Evid Rep Technol Assess (Summ); 2003 Mar 26; (76):1-4. PubMed ID: 12647510
    [No Abstract] [Full Text] [Related]

  • 3. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS, Stricker BH.
    Ned Tijdschr Geneeskd; 2002 Jul 13; 146(28):1335-6. PubMed ID: 12148223
    [Abstract] [Full Text] [Related]

  • 4. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
    Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.
    Int J Obes Relat Metab Disord; 2002 May 13; 26(5):593-604. PubMed ID: 12032741
    [Abstract] [Full Text] [Related]

  • 5. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.
    McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM.
    JAMA; 2004 Jan 14; 291(2):216-21. PubMed ID: 14722148
    [Abstract] [Full Text] [Related]

  • 6. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.
    Gurley BJ, Steelman SC, Thomas SL.
    Clin Ther; 2015 Feb 01; 37(2):275-301. PubMed ID: 25262198
    [Abstract] [Full Text] [Related]

  • 7. Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.
    Magkos F, Kavouras SA.
    Sports Med; 2004 Feb 01; 34(13):871-89. PubMed ID: 15487903
    [Abstract] [Full Text] [Related]

  • 8. Adverse events of herbal food supplements for body weight reduction: systematic review.
    Pittler MH, Schmidt K, Ernst E.
    Obes Rev; 2005 May 01; 6(2):93-111. PubMed ID: 15836459
    [Abstract] [Full Text] [Related]

  • 9. Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements.
    Miller SC.
    Mil Med; 2004 Feb 01; 169(2):87-93. PubMed ID: 15040625
    [Abstract] [Full Text] [Related]

  • 10. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M, Miotto K, Iguchi M, Jungvig L, Morton SC, Shekelle PG.
    Am J Psychiatry; 2005 Jan 01; 162(1):189-91. PubMed ID: 15625222
    [Abstract] [Full Text] [Related]

  • 11. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.
    Greenway FL.
    Obes Rev; 2001 Aug 01; 2(3):199-211. PubMed ID: 12120105
    [Abstract] [Full Text] [Related]

  • 12. Psychiatric symptoms associated with ephedra use.
    Maglione M, Miotto K, Iguchi M, Hilton L, Shekelle P.
    Expert Opin Drug Saf; 2005 Sep 01; 4(5):879-84. PubMed ID: 16111450
    [Abstract] [Full Text] [Related]

  • 13. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
    Preuss HG, DiFerdinando D, Bagchi M, Bagchi D.
    J Med; 2002 Sep 01; 33(1-4):247-64. PubMed ID: 12939122
    [Abstract] [Full Text] [Related]

  • 14. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
    Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL.
    Int J Obes (Lond); 2006 Oct 01; 30(10):1545-56. PubMed ID: 16552410
    [Abstract] [Full Text] [Related]

  • 15. Ergogenic aids: an update on ephedra.
    Keisler BD, Hosey RG.
    Curr Sports Med Rep; 2005 Aug 01; 4(4):231-5. PubMed ID: 16004835
    [Abstract] [Full Text] [Related]

  • 16. Supplemental products used for weight loss.
    Lenz TL, Hamilton WR.
    J Am Pharm Assoc (2003); 2004 Aug 01; 44(1):59-67; quiz 67-8. PubMed ID: 14965155
    [Abstract] [Full Text] [Related]

  • 17. JAMA patient page. Ephedra and ephedrine.
    Torpy JM, Lynm C, Glass RM.
    JAMA; 2003 Mar 26; 289(12):1590. PubMed ID: 12672776
    [No Abstract] [Full Text] [Related]

  • 18. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
    Haller CA, Jacob P, Benowitz NL.
    Clin Pharmacol Ther; 2005 Jun 26; 77(6):560-71. PubMed ID: 15961987
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
    Haller CA, Benowitz NL.
    N Engl J Med; 2000 Dec 21; 343(25):1833-8. PubMed ID: 11117974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.